XML 19 R9.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Jun. 30, 2020
Dec. 31, 2019
Cash and cash equivalents $ 849,079 $ 74,417 $ 78,485  
Restricted cash 59,010 [1] 16,432 15,283 [1]  
Total cash and cash equivalents and restricted cash shown in our condensed consolidated statements of cash flows $ 908,089 $ 90,849 $ 93,768 $ 52,224
Life Science Property | Joint Venture        
Ownership percentage 55.00%      
[1] As of June 30, 2021, restricted cash consists of amounts from dispositions held as collateral pursuant to the agreement governing our revolving credit facility, or our credit agreement. We may use these funds to pay for approved expenditures in accordance with our credit agreement. Restricted cash also consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties and cash held for the operations of the life science property that is owned in a joint venture arrangement in which we own a 55% equity interest.